COMP <GO>
ICLR vs INCY // EV/EBITDA & P/E VALUATION
ICON plc (NASDAQ) VS. Incyte Corp. (NASDAQ) • 15-METRIC TALLY: ICLR 3
— INCY 9
▲ EV/EBITDA & P/E VALUATION LEADER: INCY
LAST: $211.36 (-1.91%) • MKT CAP: $16.50B
valuation
31.7x
LAST: $120.39 (+3.07%) • MKT CAP: $23.68B
valuation
12.5x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ICLR VS. INCY)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ICLR | INCY | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 92.80% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 3.10% | 42.40% | -39.30 | INCY | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 31.7x | 12.5x | +19.20 | INCY | /valuation <GO> |
| Free Cash Flow Yield | 5.22% | 4.99% | +0.23 | ICLR | /fcf-yield <GO> |
| Operating Margin | 5.40% | 29.50% | -24.10 | INCY | /operating-margins <GO> |
| Net Profit Margin | 2.80% | 25.00% | -22.20 | INCY | /net-margins <GO> |
| Revenue Growth (YoY) | 0.80% | 21.20% | -20.40 | INCY | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.20 | 10.04 | -7.84 | INCY | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 9/9 | -2.00 | INCY | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 75.7 | 50.0 | +25.70 | ICLR | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.08 | 1.01 | +0.07 | ICLR | /macro-sensitivity <GO> |
| Forward P/E Multiple | 66.9x | 15.5x | +51.40 | INCY | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $16.50B | $23.68B | -$7.18B | INCY | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ICLR REV | INCY REV | ICLR GROSS % | INCY GROSS % | ICLR FCF | INCY FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $8.25B | $5.14B | — | 92.8% | $862.0M | $1.18B |
| FY 2024 | $8.19B | $4.24B | 28.6% | 92.6% | $1.12B | $144.5M |
| FY 2023 | $8.05B | $3.70B | — | — | $798.6M | $330.2M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ICLR // BETA 1.08
INCY // BETA 1.01